Karl Neff
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease (NCT01847313) | Karl Neff | 2013-04-01 |
Track Karl Neff automatically
Every clearance here is in the API, with alerts when new ones post.